William Larkins
Corporate Officer/Principal at HIKMA PHARMACEUTICALS PLC
Profile
William C.
Larkins is currently the President-Injectables Business at Hikma Pharmaceuticals Plc.
Prior to his current position, he served as the Chief Executive Officer & Director at CUSTOpharm, Inc. Dr. Larkins holds a doctorate degree from The Ohio State University and an undergraduate degree from Purdue University.
William Larkins active positions
Companies | Position | Start |
---|---|---|
HIKMA PHARMACEUTICALS PLC | Corporate Officer/Principal | 2021-12-31 |
Former positions of William Larkins
Companies | Position | End |
---|---|---|
CUSTOpharm, Inc.
CUSTOpharm, Inc. Pharmaceuticals: MajorHealth Technology CUSTOpharm, Inc. provides personalized chemistry and regulatory support services. It provides personalized cost-effective chemistry and manufacturing controls (CMC) and regulatory support to companies with limited resources and those seeking to expand into new areas. The firm offers product development services that focus on non-clinical, clinical, marketing, and other aspects of drug development and distribution; sourcing of product manufacturing with specialization in injectable dosage forms, including suspensions, lyophilized, and cytotoxic compounds, technology transfer, regulatory support, such as electronic submissions, electronic hybrids, paper applications/CTD/traditional format, structured product labeling. The company was founded by David McCleary in 2005 and is headquartered in San Diego, CA. | Chief Executive Officer | 2022-08-31 |
Training of William Larkins
Purdue University | Undergraduate Degree |
The Ohio State University | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Listed companies | 1 |
---|---|
HIKMA PHARMACEUTICALS PLC | Health Technology |
Private companies | 1 |
---|---|
CUSTOpharm, Inc.
CUSTOpharm, Inc. Pharmaceuticals: MajorHealth Technology CUSTOpharm, Inc. provides personalized chemistry and regulatory support services. It provides personalized cost-effective chemistry and manufacturing controls (CMC) and regulatory support to companies with limited resources and those seeking to expand into new areas. The firm offers product development services that focus on non-clinical, clinical, marketing, and other aspects of drug development and distribution; sourcing of product manufacturing with specialization in injectable dosage forms, including suspensions, lyophilized, and cytotoxic compounds, technology transfer, regulatory support, such as electronic submissions, electronic hybrids, paper applications/CTD/traditional format, structured product labeling. The company was founded by David McCleary in 2005 and is headquartered in San Diego, CA. | Health Technology |
- Stock Market
- Insiders
- William Larkins